Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular Lymphoma
Francesc Bosch, John Kuruvilla, Theodoros P. Vassilakopoulos, Danilo Di Maio, Michael C. Wei, Marie-Hélène Blanchet Zumofen, Loretta J. Nastoupil
Topics & Concepts
MedicineFollicular lymphomaRefractory (planetary science)OncologyInternal medicineFollicular phaseRituximabLymphomaCancer researchPhysicsAstrobiologyLymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research